A Devex signature event

Prescription for Progress

FEBRUARY 15, 2022

7:30 a.m. PT | 10:30 a.m. ET | 4:30 p.m. CET


About the Event

Prescription for Progress brings together leaders across sectors working on technology and innovation to advance global health.

Through illuminating journalism, expert analysis, and a series of discussions, it features — and inspires — partnerships between innovators and the global health community that are essential to accelerating progress on health outcomes for all. In February 2022, we’ll gather once again to dive into learnings about global health partnerships over the past year. What’s working, what isn’t, and what’s next?

Since the first edition of Prescription for Progress in October 2018, there has been growing awareness of the role Silicon Valley, and technology and innovation more broadly, must play to move the needle in global health. The onset of the COVID-19 pandemic and the growing climate crisis have made it more critical than ever for cross-sector partnerships to leverage the power of technology in order to bridge gaps in global health. Innovation isn’t just found in the Bay Area, either, and is just as likely, if not more, to come out of Nairobi, Dhaka or Bogotá.

Prescription for Progress 2022 aims to connect the people at the center of these partnerships to bring solutions to scale in the COVID-19 response and long term recovery – and to accelerate progress on global health goals more broadly.

Topics will include:
• Technology and innovation in COVID-19 response
• Advancing progress on other health priorities during COVID-19
• Digital health tools: access, scale, trust
• Partnerships at the climate-health nexus

Save your spot

Tuesday, February 15, 2022


Steve Adudans

Steve Adudans

Entrepreneur and Innovator, formerly NEST360 Kenya Country Director

Dr. Sanjeev Arora

Dr. Sanjeev Arora

Founder and director, Project ECHO.

Benjamin Fels

Benjamin Fels

CEO, Macro-Eyes

Nithya Ramanathan

Dr. Nithya Ramanathan

CEO & co-founder, Nexleaf Analytics

Dr. Neil Buddy Shah

Dr. Neil Buddy Shah

Managing director, GiveWell

Prof. Petro Terblanche

Prof. Petro Terblanche

Managing director, Afrigen Biologics


Innovation Partners:

MSD for Mothers JHU

2021 sessions